Pravastatin manufacturers, plaintiffs announce settlements in US antitrust litigation
Hospitals and independent pharmacies informed a Philadelphia federal judge on Thursday that they have secured settlement agreements with manufacturers of the generic cholesterol drug pravastatin, ending the road toward a bellwether...To view the full article, register now.
Already a subscriber? Click here to view full article